Lymphocyte-suppressing effect of simvastatin in mixed dyslipidemic patients but not impaired glucose tolerance patients

Pharmacological Reports

Volumn 63, Issue 1, 2011, Pages 95-101

  Krysiak, Robert ^a   Okopień, Bogusław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Impaired glucose tolerance; Interferon ; Interleukin 2; Lymphocytes; Mixed dyslipidemia; Simvastatin

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GAMMA INTERFERON; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 2; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOHEMAGGLUTININ; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BEDTIME DOSAGE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; DIET RESTRICTION; DRUG MECHANISM; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MIXED DYSLIPIDEMIA; PATIENT COMPLIANCE; PROTEIN BLOOD LEVEL; T LYMPHOCYTE ACTIVATION; TRIACYLGLYCEROL BLOOD LEVEL; UNSPECIFIED SIDE EFFECT;

EID: 79953195594     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(11)70403-0     Document Type: Article

References (25)

1. Athyros VG, Kakafika AI, Tziomalos K, Karagiannis A, Mikhailidis DP: Pleiotropic effects of statins-clinical evidence. Curr Pharm Des, 2009, 15, 479-489.
2. Blum A, Shamburek R: The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis, 2009, 203, 325-330.
3. Goldberg RB: Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab, 2009, 9, 3171-3182.
4. Horimoto H, Nakai Y, Nakahara K, Nomura Y, Mieno S, Sasaki S: HMG-CoA reductase inhibitor cerivastatin prolonged rat cardiac allograft survival by blocking intercellular signals. J Heart Lung Transplant, 2002, 21, 440-445. (Pubitemid 34245361)
5. Jasińska M, Owczarek J, Orszulak-Michalak D: Statins: a new insight into their mechanisms of action and consequent pleiotropic effects. Pharmacol Rep, 2007, 59 483-499.
6. Krysiak R, Okopień B, Herman ZS: Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes. Drugs, 2003, 63, 1821-1854. (Pubitemid 37083030)
7. Krysiak R, Łabuzek K, Okopień B: Effect of atorvastatin and fenofibric acid on adipokine release from visceral and subcutaneous adipose tissue of patients with mixed dyslipidemia and normolipidemic subjects. Pharmacol Rep, 2009, 60, 1134-1145.
8. Kwak B, Mulhaupt F, Myit S, Mach F: Statins as a newly recognized type of immunomodulator. Nat Med, 2000, 6, 1399-1402. (Pubitemid 32001026)
9. Kwak B, Mulhaupt F, Veillard N, Pelli G, Mach F: The HMG-CoA reductase inhibitor simvastatin inhibits IFN-γ induced MHC class II expression in human vascular endothelial cells. Swiss Med Wkly, 2001, 131, 41-66.
10. Leung BP, Sattar N, Crilly A, Prach M, McCarey DW, Payne H, Madhok R et al.: A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol, 2003, 170, 1524-1530. (Pubitemid 36139524)
11. Neuhaus O, Strasser-Fuchs S, Fazekas F, Kieseier BC, Niederwieser G, Hartung HP, Archelos JJ: Statins as immunomodulators: comparison with interferon-β 1b in MS. Neurology, 2002, 59, 990-997.
12. Okopień B, Krysiak R, Kowalski J, Madej A, Belowski D, Zieliński M, Łabuzek K, Herman ZS: The effect of statins and fibrates on interferon-γ and interleukin-2 release in patients with primary type II dyslipidemia. Atherosclerosis, 2004, 176, 327-335.
13. Okopień B, Krysiak R, Haberka M, Herman ZS: Effect of monthly atorvastatin and fenofibrate treatment on monocyte chemoattractant protein-1 release in patients with primary hypercholesterolemia. J Cardiovasc Pharmacol, 2005, 45, 314-320. (Pubitemid 40411286)
14. Petersen JL, McGuire DK: Impaired glucose tolerance and impaired fasting glucose - a review of diagnosis, clinical implications and management. Diab Vasc Dis Res, 2005, 2, 9-15. (Pubitemid 40333199)
15. Ridker PM: Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev, 2007, 65, S253-S259.
16. Ridker PM, Danielson E, Fonseca FAH, Genes J, Gotto AM, Kastelein JJP, Koenig Wet al.: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med, 2008, 359, 2195-2207.
17. Sabatine MS, Wiviott SD, Morrow DA, McCabe CH, Canon CP: High dose atorvastatin associated with worse glycemic control: a PROVE-IT TIMI 22 substudy. Circulation, 2004, 110, Suppl, S834.
18. Sadeghi MM, Tiglio A, Sadigh K, O'Donnell L, Collinge M, Pardi R, Bender JR: Inhibition of interferon-γ-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors. Transplantation, 2001, 71, 1262-1268. (Pubitemid 32507145)
19. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR et al.: Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet, 2010, 375, 735-742.
20. Tedgui A, Mallat Z: Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev, 2006, 86, 515-581.
21. Twigg SM, Kamp MC, Davis TM, Neylon EK, Flack JR; Australian Diabetes Society; Australian Diabetes Educators Association: Prediabetes: a position statement from the Australian Diabetes Society and Australian Diabetes Educators Association. Med J Aust, 2007, 186, 461-465. (Pubitemid 46806823)
22. Wallace TM, Matthews DR: The assessment of insulin resistance in man. Diabet Med., 2002, 19, 527-534. (Pubitemid 35300672)
23. Weyand CM, Younge BR, Goronzy JJ: T cells in arteritis and atherosclerosis. Curr Opin Lipidol, 2008, 19, 469-477.
24. Yamakawa T, Takano T, Tanaka S, Kadonosono K, Terauchi Y: Influence of pitavastatin on glucose tolerance in patients with type 2 diabetes mellitus. J Atheroscler Thromb, 2008, 15, 269-275.
25. Yilmaz A, Reiss C, Weng A, Cicha I, Stumpf C, Steinkasserer A, Daniel WG et al.: Differential effects of statins on relevant functions of human monocyte-derived dendritic cells. J Leukoc Biol, 2006, 79, 529-538. (Pubitemid 44831230)